ClinicalTrials.Veeva

Menu

Dilapan-S / Dilasoft E-Registry in Induced Abortion (DSREGISTRYIA)

M

Medicem

Status

Completed

Conditions

Abortion, Induced

Treatments

Device: Dilapan-S

Study type

Observational

Funder types

Industry

Identifiers

NCT02318212
DIS-2014-010

Details and patient eligibility

About

International Observational E-Registry on the use of osmotic dilators DILAPAN-S® / DILASOFT® for cervical priming prior to induced abortion.

Full description

International, multicentre, non-interventional, observational e-registry, post market clinical follow up study to document current clinical use of Dilapan-S or Dilasoft for cervical priming before induced abortion with regard to the number of dilators used, duration of insertion of dilators in situ and unusual complications consequent of their use.

Enrollment

439 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Intrauterine pregnancy ≥ 6 and ≤ 24 weeks gestation
  • Patients who are capable of giving consent and sign the form
  • Abortion being made in compliance with the Abortion Act 1967 (For England, Wales and Scotland)

Exclusion criteria

  • Clinical signs of uterine, vaginal or vulvar infection
  • Acute bleeding

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems